Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.

Andriole GL, McCullum-Hill C, Sandhu GS, Crawford ED, Barry MJ, Cantor A; CAMUS Study Group.

J Urol. 2013 Feb;189(2):486-92. doi: 10.1016/j.juro.2012.09.037. Epub 2012 Dec 14.

2.

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE Jr, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT; Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group.

JAMA. 2011 Sep 28;306(12):1344-51. doi: 10.1001/jama.2011.1364. Erratum in: JAMA. 2012 Jun 13;307(22):2374.

3.

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.

Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB.

J Urol. 2000 May;163(5):1451-6.

PMID:
10751856
4.

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.

Gerber GS, Kuznetsov D, Johnson BC, Burstein JD.

Urology. 2001 Dec;58(6):960-4; discussion 964-5.

PMID:
11744467
5.

Saw palmetto for benign prostatic hyperplasia.

Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL.

N Engl J Med. 2006 Feb 9;354(6):557-66.

6.

Saw palmetto for the treatment of men with lower urinary tract symptoms.

Gerber GS.

J Urol. 2000 May;163(5):1408-12. Review.

PMID:
10751846
7.

Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto.

Lee JY, Moore P, Kusek J, Barry M; CAMUS Study Group.

J Altern Complement Med. 2014 Jan;20(1):48-52. doi: 10.1089/acm.2012.0284. Epub 2013 Feb 5.

8.

What do I tell patients about saw palmetto for benign prostatic hyperplasia?

Kane CJ, Raheem OA, Bent S, Avins AL.

Urol Clin North Am. 2011 Aug;38(3):261-77. doi: 10.1016/j.ucl.2011.04.005. Review.

PMID:
21798388
9.

Saw palmetto for prostate disorders.

Gordon AE, Shaughnessy AF.

Am Fam Physician. 2003 Mar 15;67(6):1281-3. Review.

10.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
11.

Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.

Arruzazabala ML, Más R, Molina V, Noa M, Carbajal D, Mendoza N.

Drugs R D. 2006;7(4):233-41.

PMID:
16784248
12.

A detailed safety assessment of a saw palmetto extract.

Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, Neuhaus J, Hudes E, Shinohara K, Kane C.

Complement Ther Med. 2008 Jun;16(3):147-54. doi: 10.1016/j.ctim.2007.10.005. Epub 2008 Feb 20.

13.

Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China.

Shi R, Xie Q, Gang X, Lun J, Cheng L, Pantuck A, Rao J.

J Urol. 2008 Feb;179(2):610-5. Epub 2007 Dec 21.

PMID:
18082217
14.

Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.

Veltri RW, Marks LS, Miller MC, Bales WD, Fan J, Macairan ML, Epstein JI, Partin AW.

Urology. 2002 Oct;60(4):617-22.

PMID:
12385921
15.

Safety and toxicity of saw palmetto in the CAMUS trial.

Avins AL, Lee JY, Meyers CM, Barry MJ; CAMUS Study Group.

J Urol. 2013 Apr;189(4):1415-20. doi: 10.1016/j.juro.2012.10.002. Epub 2012 Oct 9.

16.

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.

Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA.

Urology. 1998 Jun;51(6):1003-7.

PMID:
9609640
17.

Saw palmetto supplement use and prostate cancer risk.

Bonnar-Pizzorno RM, Littman AJ, Kestin M, White E.

Nutr Cancer. 2006;55(1):21-7.

PMID:
16965237
18.

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.

Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M.

Clin Trials. 2009 Dec;6(6):628-36. doi: 10.1177/1740774509352199. Epub 2009 Dec 9.

19.

Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.

Lee JY, Foster HE Jr, McVary KT, Meleth S, Stavris K, Downey J, Kusek JW.

J Altern Complement Med. 2011 May;17(5):469-72. doi: 10.1089/acm.2010.0300. Epub 2011 May 9.

20.

Supplemental Content

Support Center